IMARC Group: Market Research Reports

The International Market Analysis Research and Consulting Group (IMARC Group) has been keeping the top position in terms of provision consultancy services on management strategy and market for above 5 years.

IMARC Group serves customers from diverse industry areas in various regions of the globe by identifying their premium-value biz opps, dealing with their most burning issues, and converting their businesses. The company bears its clients a hand in improving decision-making and strategy-planning processes as well as in moving their business to a higher level.

The reports published by IMARC offer precise information on a slew of industries such as pharmaceutical, high-technology, advanced materials, food and beverage, biotechnology, nanotechnology, tourism and travel and a far more. The reports include detailed market analyses, overviews and forecasts, reviews of the economic and technological developments, profiles of the dominant companies, market/product assessments, etc. IMARC’s research approach unites deep insight into the market dynamics together with strong cooperation with each level of the client organization.

Publications found: 11,648

Sort by:

Dysautonomia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dysautonomia markets reached a value of US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5.5 Billion by 2034, exhibiting a growth rate (CAGR) of 9.22% dur...

May 2024 131 pages

Dyskinesia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dyskinesia markets are expected to exhibit a CAGR of 3.14% during 2024-2034. The dyskinesia market has been comprehensively analyzed in IMARC's new report titled 'Dyskinesia Market: Epidem...

May 2024 130 pages

Dyslipidemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dyslipidemia markets reached a value of US$ 5.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 8.8 Billion by 2034, exhibiting a growth rate (CAGR) of 3.84% dur...

May 2024 133 pages

Dysmenorrhea Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dysmenorrhea markets reached a value of US$ 10.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 18.5 Billion by 2034, exhibiting a growth rate (CAGR) of 5.44% d...

May 2024 128 pages

Dyspepsia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dyspepsia markets are expected to exhibit a CAGR of 3.49% during 2024-2034. The dyspepsia market has been comprehensively analyzed in IMARC's new report titled 'Dyspepsia Market: Epidemiol...

May 2024 128 pages

Dyspnea Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dyspnea markets are expected to exhibit a CAGR of 5.24% during 2024-2034. The dyspnea market has been comprehensively analyzed in IMARC's new report titled 'Dyspnea Market: Epidemiology, I...

May 2024 132 pages

Dyssomnias Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dyssomnias markets reached a value of US$ 16.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 19.3 Billion by 2034, exhibiting a growth rate (CAGR) of 1.68% dur...

May 2024 139 pages

Dysthymia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dysthymia markets are expected to exhibit a CAGR of 3.7% during 2024-2034. The dysthymia market has been comprehensively analyzed in IMARC's new report titled 'Dysthymia Market: Epidemiolo...

May 2024 130 pages

Dystrophic Epidermolysis Bullosa Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034

US$ 6,499.00

The 7 major dystrophic epidermolysis bullosa markets reached a value of US$ 525.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,857.8 Million by 2034, exhibiting a growt...

May 2024 132 pages

Eczema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major eczema markets reached a value of US$ 16.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 37.1 Billion by 2034, exhibiting a growth rate (CAGR) of 7.46% during...

May 2024 136 pages

Edward’s Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Edward’s syndrome markets reached a value of US$ 3.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.6 Billion by 2034, exhibiting a growth rate (CAGR) of 7.51...

May 2024 128 pages

EGFR Inhibitors-Induced Skin Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major EGFR inhibitors-induced skin disorders markets are expected to exhibit a CAGR of 17.89% during 2024-2034. The EGFR inhibitors-induced skin disorders market has been comprehensively analyze...

May 2024 135 pages

Ehlers-Danlos Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Ehlers-Danlos syndrome markets are expected to exhibit a CAGR of 3.42% during 2024-2034. The Ehlers-Danlos syndrome market has been comprehensively analyzed in IMARC's new report titled 'E...

May 2024 138 pages

Emesis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major emesis markets are expected to exhibit a CAGR of 4.18% during 2024-2034. The emesis market has been comprehensively analyzed in IMARC's new report titled 'Emesis Market: Epidemiology, Indu...

May 2024 140 pages

Emphysema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major emphysema markets reached a value of US$ 3.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.9 Billion by 2034, exhibiting a growth rate (CAGR) of 3.84% during...

May 2024 137 pages

Encephalitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major encephalitis markets reached a value of US$ 15.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 23.4 Billion by 2034, exhibiting a growth rate (CAGR) of 4.1% du...

May 2024 137 pages

End-Stage Renal Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major end-stage renal disease markets reached a value of US$ 76.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 218.2 Billion by 2034, exhibiting a growth rate (CAGR...

May 2024 137 pages

Endocarditis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major endocarditis markets are expected to exhibit a CAGR of 4.22% during 2024-2034. The endocarditis market has been comprehensively analyzed in IMARC's new report titled 'Endocarditis Market:...

May 2024 131 pages

Endometrial Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major endometrial cancer markets reached a value of US$ 20.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 29.5 Billion by 2034, exhibiting a growth rate (CAGR) of 3...

May 2024 133 pages

Eosinophilia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major eosinophilia markets reached a value of US$ 289.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 474.5 Million by 2034, exhibiting a growth rate (CAGR) of 4.61%...

May 2024 131 pages

Eosinophilic Esophagitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major eosinophilic esophagitis markets reached a value of US$ 896.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7,604.7 Million by 2034, exhibiting a growth rate (...

May 2024 137 pages

Ependymoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major ependymoma markets are expected to exhibit a CAGR of 4.03% during 2024-2034. The ependymoma market has been comprehensively analyzed in IMARC's new report titled 'Ependymoma Market: Epidem...

May 2024 131 pages

Epidermolysis Bullosa Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major epidermolysis bullosa markets reached a value of US$ 2,596.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3,929.8 Million by 2034, exhibiting a growth rate (C...

May 2024 131 pages

Epithelial Ovarian Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major epithelial ovarian cancer markets reached a value of US$ 2.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 14.3 Billion by 2034, exhibiting a growth rate (CAGR...

May 2024 134 pages

Erdheim-Chester Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Erdheim-Chester disease markets are expected to exhibit a CAGR of 7.13% during 2024-2034. The Erdheim-Chester disease market has been comprehensively analyzed in IMARC's new report titled...

May 2024 135 pages

Erectile Dysfunction Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major erectile dysfunction markets reached a value of US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.9 Billion by 2034, exhibiting a growth rate (CAGR) of 6...

May 2024 133 pages

Erosive Esophagitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major erosive esophagitis markets are expected to exhibit a CAGR of 19.2% during 2024-2034. The erosive esophagitis market has been comprehensively analyzed in IMARC's new report titled 'Erosive...

May 2024 129 pages

Erythema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major erythema markets are expected to exhibit a CAGR of 4.38% during 2024-2034. The erythema market has been comprehensively analyzed in IMARC's new report titled 'Erythema Market: Epidemiology...

May 2024 137 pages

Erythromelalgia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major erythromelalgia markets reached a value of US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.8 Billion by 2034, exhibiting a growth rate (CAGR) of 4.94%...

May 2024 132 pages

Esophageal Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major esophageal cancer markets reached a value of US$ 9.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 16.5 Billion by 2034, exhibiting a growth rate (CAGR) of 5.7...

May 2024 137 pages

Esophageal Motility Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major esophageal motility disorders markets are expected to exhibit a CAGR of 5.93% during 2024-2034. The esophageal motility disorders market has been comprehensively analyzed in IMARC's new re...

May 2024 130 pages

Esophageal Squamous Cell Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major esophageal squamous cell carcinoma markets are expected to exhibit a CAGR of 8.1% during 2024-2034. The esophageal squamous cell carcinoma market has been comprehensively analyzed in IMARC...

May 2024 133 pages

Ewing’s Sarcoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major ewing’s sarcoma markets reached a value of US$ 47.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 74.5 Million by 2034, exhibiting a growth rate (CAGR) of 4.1%...

May 2024 135 pages

Exanthema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major exanthema markets reached a value of US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.4 Billion by 2034, exhibiting a growth rate (CAGR) of 5.32% during...

May 2024 134 pages

Exocrine Pancreatic Insufficiency Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major exocrine pancreatic insufficiency markets reached a value of US$ 2.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.0 Billion by 2034, exhibiting a growth rat...

May 2024 128 pages

Extensive-Stage Small Cell Lung Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major extensive-stage small cell lung cancer markets are expected to exhibit a CAGR of 7.6% during 2024-2034. The extensive-stage small cell lung cancer market has been comprehensively analyzed...

May 2024 131 pages

Failed Back Surgery Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major failed back surgery syndrome markets reached a value of US$ 13.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 19.6 Billion by 2034, exhibiting a growth rate (...

May 2024 129 pages

Fallopian Tube Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major fallopian tube cancer markets are expected to exhibit a CAGR of 6.96% during 2024-2034. The fallopian tube cancer market has been comprehensively analyzed in IMARC's new report titled 'Fal...

May 2024 132 pages

Familial Adenomatous Polyposis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major familial adenomatous polyposis markets are expected to exhibit a CAGR of 4.23% during 2024-2034. The familial adenomatous polyposis market has been comprehensively analyzed in IMARC's new...

May 2024 138 pages

Familial Mediterranean Fever Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major familial Mediterranean fever markets are expected to exhibit a CAGR of 4.31% during 2024-2034. The familial Mediterranean fever market has been comprehensively analyzed in IMARC's new repo...

May 2024 134 pages

Familial Primary Pulmonary Hypertension Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major familial primary pulmonary hypertension markets reached a value of US$ 5.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 8.2 Billion by 2034, exhibiting a grow...

May 2024 133 pages

Fanconi Anemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Fanconi anemia markets reached a value of US$ 49.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 78.8 Million by 2034, exhibiting a growth rate (CAGR) of 4.38%...

May 2024 134 pages

Febrile Neutropenia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major febrile neutropenia markets reached a value of US$ 10.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 16.3 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 131 pages

Fecal Incontinence Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major fecal incontinence markets reached a value of US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.2 Billion by 2034, exhibiting a growth rate (CAGR) of 3.8...

May 2024 140 pages

Female Infertility Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major female infertility markets reached a value of US$ 2.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.7 Billion by 2034, exhibiting a growth rate (CAGR) of 2.7...

May 2024 129 pages

Fibrodysplasia Ossificans Progressiva Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major fibrodysplasia ossificans progressiva markets reached a value of US$ 361.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 503.8 Million by 2034, exhibiting a gr...

May 2024 138 pages

Fibromyalgia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major fibromyalgia markets reached a value of US$ 2.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.0 Billion by 2034, exhibiting a growth rate (CAGR) of 2.69% dur...

May 2024 135 pages

Filariasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major filariasis markets are expected to exhibit a CAGR of 7.92% during 2024-2034. The filariasis market has been comprehensively analyzed in IMARC's new report titled 'Filariasis Market: Epidem...

May 2024 139 pages

Focal Segmental Glomerulosclerosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major focal segmental glomerulosclerosis markets reached a value of US$ 332.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 578.0 Million by 2034, exhibiting a growt...

May 2024 135 pages

Follicular Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major follicular lymphoma markets reached a value of US$ 1.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.2 Billion by 2034, exhibiting a growth rate (CAGR) of 3....

May 2024 129 pages

Filters

Clear all